| |
The authors would
like to acknowledge all of the individuals at the University of
Washington, Departments of Oral Medicine, Department of Dental
Public Health Sciences and Psychiatry and Behavioral Science,
and associated institutions that have made it possible to conduct
TMD research and multiple TMD clinical trials.
From the University
of Washington, these individuals are: Edmond L. Truelove, DDS,
MSD; Linda LeResche, ScD; Judy Turner, PhD; Kimberly Huggins,
RDH, BS; Lloyd Mancl, PhD; Earl Sommers, DDS, MSD; Michael Martin,
DDS, MSD, PhD; Beatrice Gandara, DDS, MSD; Gayle Garson, MA, Donna
L. Massoth, DDS MSD Ph.D, Leanne Wilson, Ph. D., Mark M. Schubert,
DDS, MSD, Jeffery J. Sherman, Ph.D. and Ernest Glass, DDS, MSD.
In addition, we acknowledge
invaluable support from The Group Health Cooperative of Puget
Sound; specifically, Michael Von Korff, ScD, and Katie Saunders,
JD. Partial financial support was also provided from National
Institute of Dental and Craniofacial Research, grant R21 DE 13722
and DE 08773-15.
|